Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Reexamination Certificate
2006-07-11
2006-07-11
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
C424S422000, C424S423000, C424S424000, C424S426000, C424S443000, C424S449000
Reexamination Certificate
active
07074425
ABSTRACT:
The present invention provides methods and compositions involving resorbable hemostatic agents that have the essential absence of microfibrillar collagen. Resorbable hemostatic agents of the present invention comprise polyethylene glycol, which controls bleeding in tissue and does not delay or interfere with healing. The resorbable hemostatic agents of the present invention are biodegradable and biocompatible agents that effectively control bleeding in bone and other tissue without interfering with the subsequent healing of the tissue.
REFERENCES:
patent: 4439420 (1984-03-01), Mattei et al.
patent: 4668295 (1987-05-01), Bajpai
patent: 5583114 (1996-12-01), Barrows et al.
patent: 5595735 (1997-01-01), Saferstein et al.
patent: 5635162 (1997-06-01), Fischer et al.
patent: 5681873 (1997-10-01), Norton et al.
patent: 6011011 (2000-01-01), Hageman
patent: 6083522 (2000-07-01), Chu et al.
patent: 6096309 (2000-08-01), Prior et al.
patent: 6117444 (2000-09-01), Orgill et al.
patent: 6294287 (2001-09-01), Lee et al.
patent: 6420454 (2002-07-01), Wenz et al.
patent: 6426332 (2002-07-01), Rueger et al.
patent: 6458147 (2002-10-01), Cruise et al.
patent: 6458889 (2002-10-01), Trollsas
patent: 6534491 (2003-03-01), Levin et al.
patent: 6566345 (2003-05-01), Miller et al.
patent: 6624245 (2003-09-01), Wallace et al.
patent: 2002/0010150 (2002-01-01), Cortese et al.
patent: 2003/0004568 (2003-01-01), Ken et al.
patent: 2003/0104031 (2003-06-01), Dumont et al.
patent: 07 118157 (1995-05-01), None
patent: 2 034 572 (1995-10-01), None
patent: WO 92/13495 (1992-08-01), None
patent: WO 01/97871 (2001-12-01), None
Aanals of Surgery, vol. 132, pp. 1128-1130, “New Absorbable Hemostatic Bone Wax”, Dr. Geary et al. 1950.
Orgill et al “Polyethylene glycol/microfibrillar collagen compositive as a new resorbable hemostatic bone wax” J. Biomed Mater Res. Mar. 5, 1998; vol. 39 No. 3: pp. 358-363. (Abstract))
New synthetic absorbable polymers as BMP carriers: plastic properties of poly-D, L-tactic acid-polyethylene glycol block copolymers J. Biomed Mater Res. Oct. 1999; vol. 47 No. 1: pp. 104-110 (Abstract).
Orgill, et al. “Polyethylene glycol/microfibrilar collagen composite as a new resorbable hemostatic bone wax”. J. Biomed Mater Res. Mar. 5, 1998;39(3) -Abstract.
Supplementary Partial European Search Report.
Constantine Barry E.
Lauritzen Nels J.
Bonewax, LLC
Ghali Isis
Kalow & Springut LLP
Page Thurman K.
Schmidt William D.
LandOfFree
Hemostatic compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hemostatic compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hemostatic compositions and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3605840